PubRank
Search
About
Barbara Sennino
Author PubWeight™ 35.80
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
J Clin Invest
2006
6.12
2
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.
Am J Physiol Heart Circ Physiol
2005
5.56
3
Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling.
Am J Physiol Heart Circ Physiol
2005
3.28
4
VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer.
Cancer Res
2011
1.92
5
Iron administration before stem cell harvest enables MR imaging tracking after transplantation.
Radiology
2013
1.70
6
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
Am J Pathol
2003
1.39
7
Cell labeling with the positive MR contrast agent Gadofluorine M.
Eur Radiol
2007
1.32
8
The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells.
Contrast Media Mol Imaging
2009
1.24
9
Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis.
Proc Natl Acad Sci U S A
2008
1.20
10
Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.
Radiology
2008
1.17
11
Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells.
Magn Reson Med
2009
1.17
12
MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritis.
Invest Radiol
2010
1.02
13
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis.
J Immunol
2003
1.00
14
Labeling human mesenchymal stem cells with fluorescent contrast agents: the biological impact.
Mol Imaging Biol
2011
1.00
15
Increased vascular delivery and efficacy of chemotherapy after inhibition of platelet-derived growth factor-B.
Am J Pathol
2011
0.99
16
Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells in cartilage defects: in vitro and in vivo investigations.
Mol Imaging
2012
0.97
17
An optical imaging method to monitor stem cell migration in a model of immune-mediated arthritis.
Opt Express
2009
0.85
18
Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers.
Eur Radiol
2008
0.83
19
Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).
Eur J Radiol
2011
0.83
20
MR imaging features of gadofluorine-labeled matrix-associated stem cell implants in cartilage defects.
PLoS One
2012
0.82
21
Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature.
Invest Radiol
2008
0.78
22
Magnetic resonance imaging of stem cell apoptosis in arthritic joints with a caspase activatable contrast agent.
ACS Nano
2015
0.76
23
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells.
Oncogene
2002
0.76